The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as ...
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat ...
The FDA approved a new nasal spray to reverse the effects of an opioid overdose. Ready why the application for this drug was ...
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
Weishapl is uncertain just how much good the FDA approval will do for the ongoing opioid crisis. “It’s cool, but unless people get it for free, it’s not going to help,” he said.
Narcan nasal spray for the treatment of opioid overdoses PHOTO COURTESY OF LAIST.COM VIA STOCK PHOTO WASHINGTON (AP) – U.S.
After a more than 4-year battle, Plymouth Meeting biotechnology firm Braeburn Inc. has received FDA approval for its opioid ...
In Pennsylvania, residents have access to free naloxone by mail. Now, with new FDA approval, naloxone nasal spray could be for sale in convenience stores, supermarkets and even online by late ...
Weishapl is uncertain just how much good the FDA approval will do for the ongoing opioid crisis. “It’s cool, but unless people get it for free, it’s not going to help,” he said.
The Food and Drug Administration on Monday approved Opvee, the first prescription nasal spray for opioid overdoses using nalmefene hydrochloride.
